Literature DB >> 11739337

The association between funding by commercial interests and study outcome in randomized controlled drug trials.

J Yaphe1, R Edman, B Knishkowy, J Herman.   

Abstract

BACKGROUND: Previous studies limited to specific drugs or journal types have shown an association between the source of funding of research and the published results.
OBJECTIVE: The aim of the present study was to determine the association between source of support of research and published outcomes of randomized controlled drug trials in general interest medical journals.
METHODS: Randomized controlled drug trials (n = 314) published in five general interest medical journals over a 2-year period were reviewed. Study outcome was classified as positive or negative. Support was classified as pharmaceutical industry or non-industry. Association between source of support and outcome was tested with the chi-squared statistic.
RESULTS: Positive findings were found in 77% of studies, negative findings in 20% and an uncertain outcome in 3%. Support from commercial sources was found in 68% of trials. Negative findings were found in 13% of industry-supported studies and in 35% of non-industry-supported studies (chi-squared = 18.36, P < 0.0001, odds ratio = 3.54, 95% confidence interval 1.90-6.62).
CONCLUSIONS: An association was found between the source of study support and the published outcome. Though the reason for this association cannot be determined from the data collected, future studies may clarify the importance of this finding for readers concerned with the relationship of funding bodies to the publication of research outcomes.

Keywords:  Biomedical and Behavioral Research; Empirical Approach

Mesh:

Year:  2001        PMID: 11739337     DOI: 10.1093/fampra/18.6.565

Source DB:  PubMed          Journal:  Fam Pract        ISSN: 0263-2136            Impact factor:   2.267


  34 in total

1.  Systematic review of anticholinergic agents: clinical trials versus clinical effectiveness.

Authors:  David R Staskin
Journal:  Curr Urol Rep       Date:  2003-12       Impact factor: 3.092

Review 2.  Pharmaceutical industry sponsorship and research outcome and quality: systematic review.

Authors:  Joel Lexchin; Lisa A Bero; Benjamin Djulbegovic; Otavio Clark
Journal:  BMJ       Date:  2003-05-31

3.  Relationship between conflicts of interest and research results.

Authors:  Lee S Friedman; Elihu D Richter
Journal:  J Gen Intern Med       Date:  2004-01       Impact factor: 5.128

4.  The impact of conflict of interest on trust in science.

Authors:  Paul J Friedman
Journal:  Sci Eng Ethics       Date:  2002-07       Impact factor: 3.525

5.  Comparison of methadone and buprenorphine for opiate detoxification (LEEDS trial): a randomised controlled trial.

Authors:  Nat M J Wright; Laura Sheard; Clive E Adams; Bruno J Rushforth; Wendy Harrison; Nicole Bound; Roger Hart; Charlotte N E Tompkins
Journal:  Br J Gen Pract       Date:  2011-12       Impact factor: 5.386

6.  The financing of drug trials by pharmaceutical companies and its consequences. Part 1: a qualitative, systematic review of the literature on possible influences on the findings, protocols, and quality of drug trials.

Authors:  Gisela Schott; Henry Pachl; Ulrich Limbach; Ursula Gundert-Remy; Wolf-Dieter Ludwig; Klaus Lieb
Journal:  Dtsch Arztebl Int       Date:  2010-04-23       Impact factor: 5.594

7.  Association of industry funding with the outcome and quality of randomized controlled trials of drug therapy for rheumatoid arthritis.

Authors:  Nasim A Khan; Juan I Lombeida; Manisha Singh; Horace J Spencer; Karina D Torralba
Journal:  Arthritis Rheum       Date:  2012-07

8.  The availability of references and the sponsorship of original research cited in pharmaceutical advertisements.

Authors:  Richelle J Cooper; David L Schriger
Journal:  CMAJ       Date:  2005-02-15       Impact factor: 8.262

9.  Conflict of Interest Disclosure Policies and Practices in Peer-reviewed Biomedical Journals.

Authors:  Richelle J Cooper; Malkeet Gupta; Michael S Wilkes; Jerome R Hoffman
Journal:  J Gen Intern Med       Date:  2006-12       Impact factor: 5.128

10.  Evolution of the randomized controlled trial in oncology over three decades.

Authors:  Christopher M Booth; David W Cescon; Lisa Wang; Ian F Tannock; Monika K Krzyzanowska
Journal:  J Clin Oncol       Date:  2008-10-27       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.